Molecular, immunological and neurophysiological evaluations for early diagnosis of neural impairment in seropositive leprosy household contacts
Conclusions/SgnificanceELISA anti-PGL-I is the most important test in determining the increased chance of neural impairment in asymptomatic leprosy household contacts. The combination of the two assays (ELISA anti-PGL-I and peripheral blood qPCR) and the presence of BCG scar may identify individuals with higher chances of developing leprosy neuropathy, corroborating with the early diagnosis and treatment.
Source: PLoS Neglected Tropical Diseases - Category: Tropical Medicine Authors: Diogo Fernandes dos Santos Source Type: research
More News: Allergy & Immunology | Brain | Leprosy | Men | Neurology | Papanicolaou (Pap) Smear | Skin | Skin Biopsy | Tropical Medicine | Tuberculosis (BCG) Vaccine | Vaccines